Listed

Mereo BioPharma Group plc

MREONasdaqCIK 1719714HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$7.0m, Q2 FY2026
Net income−$7.0m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, period not labelled, three months to 2023-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure1.0Revenue, Q4 FY2023, three months to 2023-12-31$1.0m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-26, accession 0000950170-25-044787. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2024-05-15, accession 0000950170-24-060497.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-12, accession 0001193125-25-178489.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.5Revenue, Q2 FY2025, three months to 2025-06-30$500.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure
Research and development$m3.6Research and development, period not labelled, three months to 2023-09-30$3.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure4.8Research and development, Q4 FY2023, three months to 2023-12-31$4.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-26, accession 0000950170-25-044787. Derived: 12-month figure less the 9-month figure.Report this figure4.0Research and development, Q1 FY2024, three months to 2024-03-31$4.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure4.9Research and development, Q2 FY2024, three months to 2024-06-30$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001193125-25-178489.Report this figure3.2Research and development, Q3 FY2024, three months to 2024-09-30$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure8.8Research and development, Q4 FY2024, three months to 2024-12-31$8.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure3.9Research and development, Q1 FY2025, three months to 2025-03-31$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure5.4Research and development, Q2 FY2025, three months to 2025-06-30$5.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure4.3Research and development, Q3 FY2025, three months to 2025-09-30$4.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure4.2Research and development, Q4 FY2025, three months to 2025-12-31$4.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure4.7Research and development, Q1 FY2026, three months to 2026-03-31$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure1.8Research and development, Q2 FY2026, three months to 2026-06-30$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure
Operating income$m(9.1)Operating income, period not labelled, three months to 2023-09-30−$9.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure(7.1)Operating income, Q4 FY2023, three months to 2023-12-31−$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-26, accession 0000950170-25-044787. Derived: 12-month figure less the 9-month figure.Report this figure(9.9)Operating income, Q1 FY2024, three months to 2024-03-31−$9.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure(12.8)Operating income, Q2 FY2024, three months to 2024-06-30−$12.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001193125-25-178489.Report this figure(9.4)Operating income, Q3 FY2024, three months to 2024-09-30−$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure(15.3)Operating income, Q4 FY2024, three months to 2024-12-31−$15.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure(11.2)Operating income, Q1 FY2025, three months to 2025-03-31−$11.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure(10.5)Operating income, Q2 FY2025, three months to 2025-06-30−$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure(10.0)Operating income, Q3 FY2025, three months to 2025-09-30−$10.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure(8.4)Operating income, Q4 FY2025, three months to 2025-12-31−$8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure(8.8)Operating income, Q1 FY2026, three months to 2026-03-31−$8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure(7.0)Operating income, Q2 FY2026, three months to 2026-06-30−$7.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure
Interest expense$m0.7Interest expense, period not labelled, three months to 2023-09-30$700.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure0.4Interest expense, Q4 FY2023, three months to 2023-12-31$353.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-26, accession 0000950170-25-044787. Derived: 12-month figure less the 9-month figure.Report this figure0.3Interest expense, Q1 FY2024, three months to 2024-03-31$310.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure0.3Interest expense, Q2 FY2024, three months to 2024-06-30$331.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-12, accession 0001193125-25-178489.Report this figure0.4Interest expense, Q3 FY2024, three months to 2024-09-30$353.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure0.4Interest expense, Q4 FY2024, three months to 2024-12-31$375.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure0.2Interest expense, Q1 FY2025, three months to 2025-03-31$180.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$24.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$28.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$23.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$20.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$16.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure
Income tax$m0.0Income tax, period not labelled, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure(0.5)Income tax, Q4 FY2023, three months to 2023-12-31−$532.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-26, accession 0000950170-25-044787. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001193125-25-178489.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure
Net income$m(6.5)Net income, period not labelled, three months to 2023-09-30−$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure(9.1)Net income, Q4 FY2023, three months to 2023-12-31−$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-26, accession 0000950170-25-044787. Derived: 12-month figure less the 9-month figure.Report this figure(9.0)Net income, Q1 FY2024, three months to 2024-03-31−$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure(12.3)Net income, Q2 FY2024, three months to 2024-06-30−$12.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure(15.0)Net income, Q3 FY2024, three months to 2024-09-30−$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure(7.0)Net income, Q4 FY2024, three months to 2024-12-31−$7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure(12.9)Net income, Q1 FY2025, three months to 2025-03-31−$12.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure(14.6)Net income, Q2 FY2025, three months to 2025-06-30−$14.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure(7.0)Net income, Q3 FY2025, three months to 2025-09-30−$7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure(7.4)Net income, Q4 FY2025, three months to 2025-12-31−$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure(6.7)Net income, Q1 FY2026, three months to 2026-03-31−$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure(7.0)Net income, Q2 FY2026, three months to 2026-06-30−$7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure
Diluted EPS$ per share(0.01)Diluted EPS, period not labelled, three months to 2023-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figurenot reported(0.01)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure(0.02)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure(0.02)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figurenot reported(0.02)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure(0.02)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure(0.01)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figurenot reported(0.01)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure(0.01)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure
Basic EPS$ per share(0.01)Basic EPS, period not labelled, three months to 2023-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figurenot reported(0.01)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure(0.02)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure(0.02)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figurenot reported(0.02)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure(0.02)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure(0.01)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figurenot reported(0.01)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure(0.01)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure

Balance sheet

Cash and equivalents$30.1m, Q2 FY2026
Shareholders' equity$28.7m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported57.4Cash and equivalents, FY2023, at 2023-12-31$57.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-26, accession 0000950170-25-044787.Report this figure48.7Cash and equivalents, Q1 FY2024, at 2024-03-31$48.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0000950170-24-060497.Report this figure87.4Cash and equivalents, Q2 FY2024, at 2024-06-30$87.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0000950170-24-095777.Report this figure80.5Cash and equivalents, Q3 FY2024, at 2024-09-30$80.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure69.8Cash and equivalents, FY2024, at 2024-12-31$69.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001193125-26-115226.Report this figure62.5Cash and equivalents, Q1 FY2025, at 2025-03-31$62.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure56.1Cash and equivalents, Q2 FY2025, at 2025-06-30$56.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001193125-25-178489.Report this figure48.7Cash and equivalents, Q3 FY2025, at 2025-09-30$48.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure41.0Cash and equivalents, FY2025, at 2025-12-31$41.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure30.1Cash and equivalents, Q1 FY2026, at 2026-03-31$30.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure30.1Cash and equivalents, Q2 FY2026, at 2026-06-30$30.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure
Current assets$mnot reported63.8Current assets, FY2023, at 2023-12-31$63.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-26, accession 0000950170-25-044787.Report this figure53.5Current assets, Q1 FY2024, at 2024-03-31$53.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060497.Report this figure93.9Current assets, Q2 FY2024, at 2024-06-30$93.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-095777.Report this figure86.7Current assets, Q3 FY2024, at 2024-09-30$86.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure74.8Current assets, FY2024, at 2024-12-31$74.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001193125-26-115226.Report this figure66.9Current assets, Q1 FY2025, at 2025-03-31$66.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure61.4Current assets, Q2 FY2025, at 2025-06-30$61.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001193125-25-178489.Report this figure52.4Current assets, Q3 FY2025, at 2025-09-30$52.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure45.0Current assets, FY2025, at 2025-12-31$45.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure40.0Current assets, Q1 FY2026, at 2026-03-31$40.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure33.4Current assets, Q2 FY2026, at 2026-06-30$33.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure
Total assets$mnot reported66.5Total assets, FY2023, at 2023-12-31$66.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-26, accession 0000950170-25-044787.Report this figure55.9Total assets, Q1 FY2024, at 2024-03-31$55.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0000950170-24-060497.Report this figure96.1Total assets, Q2 FY2024, at 2024-06-30$96.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-095777.Report this figure88.7Total assets, Q3 FY2024, at 2024-09-30$88.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure76.4Total assets, FY2024, at 2024-12-31$76.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001193125-26-115226.Report this figure68.3Total assets, Q1 FY2025, at 2025-03-31$68.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure62.6Total assets, Q2 FY2025, at 2025-06-30$62.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001193125-25-178489.Report this figure53.6Total assets, Q3 FY2025, at 2025-09-30$53.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure45.9Total assets, FY2025, at 2025-12-31$45.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure40.6Total assets, Q1 FY2026, at 2026-03-31$40.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure34.7Total assets, Q2 FY2026, at 2026-06-30$34.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure
Current liabilities$mnot reported9.5Current liabilities, FY2023, at 2023-12-31$9.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-26, accession 0000950170-25-044787.Report this figure11.0Current liabilities, Q1 FY2024, at 2024-03-31$11.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-060497.Report this figure15.5Current liabilities, Q2 FY2024, at 2024-06-30$15.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-095777.Report this figure14.2Current liabilities, Q3 FY2024, at 2024-09-30$14.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure13.8Current liabilities, FY2024, at 2024-12-31$13.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001193125-26-115226.Report this figure7.5Current liabilities, Q1 FY2025, at 2025-03-31$7.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure7.6Current liabilities, Q2 FY2025, at 2025-06-30$7.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001193125-25-178489.Report this figure6.0Current liabilities, Q3 FY2025, at 2025-09-30$6.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure4.3Current liabilities, FY2025, at 2025-12-31$4.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure6.2Current liabilities, Q1 FY2026, at 2026-03-31$6.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure5.7Current liabilities, Q2 FY2026, at 2026-06-30$5.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure
Total liabilities$mnot reported16.0Total liabilities, FY2023, at 2023-12-31$16.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-26, accession 0000950170-25-044787.Report this figure13.1Total liabilities, Q1 FY2024, at 2024-03-31$13.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0000950170-24-060497.Report this figure17.5Total liabilities, Q2 FY2024, at 2024-06-30$17.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-095777.Report this figure16.2Total liabilities, Q3 FY2024, at 2024-09-30$16.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure15.4Total liabilities, FY2024, at 2024-12-31$15.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001193125-26-115226.Report this figure8.2Total liabilities, Q1 FY2025, at 2025-03-31$8.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure8.5Total liabilities, Q2 FY2025, at 2025-06-30$8.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001193125-25-178489.Report this figure7.0Total liabilities, Q3 FY2025, at 2025-09-30$7.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure5.0Total liabilities, FY2025, at 2025-12-31$5.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure6.6Total liabilities, Q1 FY2026, at 2026-03-31$6.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure6.1Total liabilities, Q2 FY2026, at 2026-06-30$6.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure
Shareholders' equity$m54.7Shareholders' equity, period not labelled, at 2023-09-30$54.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure50.5Shareholders' equity, FY2023, at 2023-12-31$50.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001193125-26-115226.Report this figure42.8Shareholders' equity, Q1 FY2024, at 2024-03-31$42.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure78.7Shareholders' equity, Q2 FY2024, at 2024-06-30$78.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure(72.5)Shareholders' equity, Q3 FY2024, at 2024-09-30−$72.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure61.0Shareholders' equity, FY2024, at 2024-12-31$61.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure60.1Shareholders' equity, Q1 FY2025, at 2025-03-31$60.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure54.2Shareholders' equity, Q2 FY2025, at 2025-06-30$54.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure46.6Shareholders' equity, Q3 FY2025, at 2025-09-30$46.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure40.9Shareholders' equity, FY2025, at 2025-12-31$40.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure34.1Shareholders' equity, Q1 FY2026, at 2026-03-31$34.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure28.7Shareholders' equity, Q2 FY2026, at 2026-06-30$28.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure

Cash flow

Operating cash flow−$6.0m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k2,659Operating cash flow, period not labelled, three months to 2023-09-30$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-124637. Derived: 9-month figure less the 6-month figure.Report this figure(6,789)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-26, accession 0000950170-25-044787. Derived: 12-month figure less the 9-month figure.Report this figure(7,991)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure(7,904)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$7.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001193125-25-178489. Derived: 6-month figure less the 3-month figure.Report this figure(7,519)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$7.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274272. Derived: 9-month figure less the 6-month figure.Report this figure(9,420)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$9.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure(8,329)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure(7,651)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$7.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343533. Derived: 6-month figure less the 3-month figure.Report this figure(7,309)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274272. Derived: 9-month figure less the 6-month figure.Report this figure(7,682)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$7.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure(4,312)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure(6,043)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343533. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$knot reportednot reported0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001193125-25-178489. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-274272. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure20.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$20.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343533. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001193125-25-274272. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001193125-26-115226. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343533. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)803.56m, Q2 FY2026
Line itemUnitperiod not labelled2023-03-31period not labelled2023-06-30period not labelled2023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares624Diluted shares (weighted), period not labelled, three months to 2023-03-31623,925,635 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0000950170-24-060497.Report this figure628Diluted shares (weighted), period not labelled, three months to 2023-06-30628,421,064 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-095777.Report this figure685Diluted shares (weighted), period not labelled, three months to 2023-09-30684,974,190 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-124637.Report this figure700Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31700,263,490 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0000950170-25-069816.Report this figure770Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30770,146,589 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure770Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30770,146,589 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure784Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31784,279,387 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure799Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30799,435,329 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure800Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30799,947,013 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001193125-25-274272.Report this figure802Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31801,805,570 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-218232.Report this figure804Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30803,562,708 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure

Shares outstanding: 798.45mShares outstanding, period not labelled, at 2026-08-07798,454,864 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343533.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.